Chongqing Zhifei Biological Products Co Ltd - Class A

SZSE:300122 (China)   Class A
Â¥ 34.83 (+1.81%) Apr 26
11.12
P/B:
2.55
Market Cap:
Â¥ 83.38B ($ 11.51B)
Enterprise V:
Â¥ 83.96B ($ 11.59B)
Volume:
27.69M
Avg Vol (2M):
20.51M
Volume:
27.69M
Avg Vol (2M):
20.51M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Chongqing Zhifei Biological Products Co Ltd ( ) from 2010 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Chongqing Zhifei Biological Products stock (SZSE:300122) PE ratio as of Apr 26 2024 is 11.12. More Details

Chongqing Zhifei Biological Products Co Ltd (SZSE:300122) PE Ratio (TTM) Chart

To

Chongqing Zhifei Biological Products Co Ltd (SZSE:300122) PE Ratio (TTM) Historical Data

Total 1173
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Chongqing Zhifei Biological Products PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-26 11.2 2024-02-21 15.9
2024-04-25 10.9 2024-02-20 15.8
2024-04-24 10.9 2024-02-19 16.0
2024-04-23 11.3 2024-02-08 15.3
2024-04-22 12.9 2024-02-07 15.4
2024-04-19 13.0 2024-02-06 15.3
2024-04-18 13.2 2024-02-05 14.1
2024-04-17 13.5 2024-02-02 13.2
2024-04-16 13.4 2024-02-01 13.6
2024-04-15 13.3 2024-01-31 13.4
2024-04-12 13.1 2024-01-30 13.7
2024-04-11 13.5 2024-01-29 14.1
2024-04-10 14.0 2024-01-26 14.5
2024-04-09 14.4 2024-01-25 14.8
2024-04-08 14.1 2024-01-24 14.7
2024-04-03 14.5 2024-01-23 14.6
2024-04-02 14.7 2024-01-22 14.4
2024-04-01 14.9 2024-01-19 14.7
2024-03-29 14.4 2024-01-18 14.8
2024-03-28 14.5 2024-01-17 14.4
2024-03-27 13.5 2024-01-16 14.6
2024-03-26 14.0 2024-01-15 14.7
2024-03-25 13.8 2024-01-12 15.1
2024-03-22 14.1 2024-01-11 15.4
2024-03-21 14.4 2024-01-10 15.6
2024-03-20 14.7 2024-01-09 16.5
2024-03-19 15.0 2024-01-08 16.6
2024-03-18 15.0 2024-01-05 16.8
2024-03-15 15.1 2024-01-04 17.2
2024-03-14 15.4 2024-01-03 17.5
2024-03-13 15.9 2024-01-02 17.8
2024-03-12 16.1 2023-12-29 18.2
2024-03-11 15.1 2023-12-28 17.8
2024-03-08 14.8 2023-12-27 16.8
2024-03-07 15.3 2023-12-26 16.4
2024-03-06 15.8 2023-12-25 16.4
2024-03-05 15.9 2023-12-22 16.4
2024-03-04 16.2 2023-12-21 16.5
2024-03-01 15.8 2023-12-20 16.8
2024-02-29 15.9 2023-12-19 16.7
2024-02-28 15.7 2023-12-18 17.2
2024-02-27 16.1 2023-12-15 17.1
2024-02-26 15.9 2023-12-14 18.7
2024-02-23 15.8 2023-12-13 18.5
2024-02-22 15.6 2023-12-12 18.4

Chongqing Zhifei Biological Products Co Ltd (SZSE:300122) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Chongqing Zhifei Biological Products Co Ltd is a biotech company. It is a Chinese firm and engaged in the research and development, production, Distribution and import and export and sale of vaccines.